Publication | Closed Access
Combining CDK4/6 inhibition with taxanes enhances anti-tumor efficacy by sustained impairment of pRB-E2F pathways in squamous cell lung cancer
44
Citations
35
References
2019
Year
Prb-e2f PathwaysCdk4/6 InhibitionMedicineSustained ImpairmentBronchial NeoplasmCancer BiologyTumor SuppressorRadiation OncologyOncologyCell BiologyLung CancerTumor Biology
| Year | Citations | |
|---|---|---|
Page 1
Page 1